MVP
Basic information
Region (hg38): 16:29820394-29848039
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MVP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 53 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 8 | 4 |
Variants in MVP
This is a list of pathogenic ClinVar variants found in the MVP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-29830589-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
16-29830629-G-A | Benign (Mar 29, 2018) | |||
16-29830659-G-A | not specified | Uncertain significance (Jun 28, 2023) | ||
16-29830897-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
16-29830898-G-A | not specified | Uncertain significance (Jul 09, 2024) | ||
16-29830906-A-T | not specified | Uncertain significance (Sep 03, 2024) | ||
16-29830909-G-A | Likely benign (May 16, 2018) | |||
16-29830919-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
16-29830949-C-G | not specified | Uncertain significance (Nov 12, 2024) | ||
16-29830952-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
16-29830993-G-T | not specified | Uncertain significance (May 29, 2024) | ||
16-29830997-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
16-29831057-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
16-29833749-A-G | not specified | Uncertain significance (Jul 02, 2024) | ||
16-29833766-A-T | not specified | Uncertain significance (Mar 08, 2024) | ||
16-29833824-T-A | not specified | Uncertain significance (Dec 19, 2022) | ||
16-29833846-C-T | Likely benign (Jul 01, 2022) | |||
16-29833943-A-C | not specified | Uncertain significance (May 23, 2023) | ||
16-29833950-G-A | not specified | Likely benign (Aug 17, 2021) | ||
16-29834013-G-T | not specified | Uncertain significance (Jan 03, 2024) | ||
16-29834034-G-T | not specified | Uncertain significance (Dec 27, 2022) | ||
16-29834060-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
16-29835725-C-G | not specified | Uncertain significance (Dec 14, 2023) | ||
16-29835746-C-T | not specified | Uncertain significance (Jul 30, 2024) | ||
16-29835772-G-A | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MVP | protein_coding | protein_coding | ENST00000357402 | 14 | 27641 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.76e-8 | 0.999 | 125603 | 0 | 145 | 125748 | 0.000577 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.02 | 431 | 566 | 0.762 | 0.0000376 | 5684 |
Missense in Polyphen | 227 | 298.44 | 0.76061 | 2953 | ||
Synonymous | 0.564 | 235 | 246 | 0.954 | 0.0000162 | 1915 |
Loss of Function | 2.87 | 18 | 36.8 | 0.489 | 0.00000183 | 412 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000814 | 0.000809 |
Ashkenazi Jewish | 0.000300 | 0.000298 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00185 | 0.00157 |
European (Non-Finnish) | 0.000653 | 0.000633 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000362 | 0.000359 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Required for normal vault structure. Vaults are multi- subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo- cytoplasmic transport. Down-regulates IFNG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. {ECO:0000269|PubMed:15133037, ECO:0000269|PubMed:16418217, ECO:0000269|PubMed:16441665}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- -0.81
- rvis_percentile_EVS
- 12.05
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.558
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mvp
- Phenotype
- normal phenotype;
Zebrafish Information Network
- Gene name
- mvp
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- protein transport;negative regulation of signaling;negative regulation of protein autophosphorylation;ERBB signaling pathway;neutrophil degranulation;mRNA transport;negative regulation of protein tyrosine kinase activity
- Cellular component
- extracellular region;nucleus;nuclear pore;cytoplasm;cytosol;cytoskeleton;membrane;secretory granule lumen;perinuclear region of cytoplasm;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- protein binding;protein kinase binding;protein phosphatase binding;identical protein binding